Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: The Rancho Bernardo study

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 2, 2000, Pages 645-651

  Laughlin, Gail A ^a   Barrett Connor, Elizabeth ^a   Kritz Silverstein, Donna ^a   Von Mühlen, Denise ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

ADULT; AGE; AGED; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AGING; ANDROSTENEDIONE; ESTRONE; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYSTERECTOMY; LIFE STYLE; MENOPAUSE; OVARIECTOMY;

EID: 0034453155     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.2.645     Document Type: Article

References (60)

1. Hysterectomy and ovarian removal: A major health issue in the perimenopausal years
2. Hysterectomy in the United States, 1965-84
3. Hysterectomy in the United States, 1988-1990
4. Ovarian cancer in women with prior hysterectomy: A 14-year experience at the University of Miami
5. Indications for hysterectomy
6. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland
7. Testosterone deficiency; A key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging?
8. Endocrine function of the postmenopausal ovary: Concentration of androgens and estrogens in ovarian and peripheral vein blood
9. Ovarian and peripheral plasma levels of progestogens, androgens, and oestrogens in post-menopausal women
10. Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopansal women
11. Endocrine activity of the postmenopausal ovary: The effects of pituitary down-regulation and oophorectomy
12. Steroid secretion by the postmenopausal ovary
13. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer
14. Plasma hormone profiles after the menopause and bilateral oophorectomy
15. A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma
16. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives
17. Inappropriate gonadotropin secretion in polycystic ovary syndrome: Influence of adiposity
18. Ovaries, androgens and the menopause: Practical applications
19. The hormonal activity of the postmenopausal ovary
20. Non-sex hormone-binding globulin-bound testosterone as a marker for hyperandrogenism
21. Ovarian failure phenomenon after hysterectomy
22. The fate of the retained ovaries following radical hysterectomy
23. Androgen and estrogen dynamics: Relationships with age, weight, and menopausal status
24. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density
25. The endocrine transition around menopause: A five years prospective study with profiles of gonadotropins, estrogens, androgens and SHBG among healthy women
26. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years
27. Hormonal profiles after the menopause
28. Androgens and the menopause; A study of 40-60-year-old women
29. Changes in circulating steroids with aging in postmenopausal women
30. Factors affecting sex hormone levels in postmenopausal women
31. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging
32. The epidemiology of serum sex hormones in postmenopausal women
33. The ovarian life cycle
34. Effects of aging and obesity on aromatase activity of human adipose cells
35. Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age
36. Serum gonadotropins and α-subunit decline in aging normal postmenopausal women
37. Variation with age in the levels of sex-steroid-binding plasma protein as determined by radioimmunoassay
38. Relationship between circulating insulin-like-growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women
39. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males
40. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: Recent advances
41. Effects of insulin-like growth factor-type 1 (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells
42. Regulation of sex hormone-binding globulin production by growth factors
43. Differential effects of insulin and insulin-like growth factor 1 on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells
44. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3 year period
45. Reliability and interrelations among serum sex hormones in postmenopausal women
46. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period
47. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma
48. Stability of steroids in plasma over a 10-year period
49. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women
50. Effect of testosterone therapy on bone formation in an osteoporotic male
51. Androgen and estrogen dynamics in women with vertebral crush fractures
52. Total and free estrogens and androgens in postmenopausal women with hip fractures
53. Sex steroids and bone mass. A study of changes about the time of menopause
54. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality
55. Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause
56. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause
57. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate
58. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses
59. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women